A summary of state of the art COVID treatment
Prevention
Our most effective weapons are lockdowns, masks, distancing, ventilation and vaccination, but we can also protect close patient contacts pharmacologically. Subcutaneous REGEN-COV (Regeneron’s monoclonal antibody combo, casirivimab plus imdevimab) lowers the rate of illness by a whopping 81.4%. This has been known since April and blessed by the FDA in July, but has yet to catch on.
Outpatient therapy
A year and …